We provide you with 20 years of free, institutional-grade data for GSK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GSK. Explore the full financial landscape of GSK stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| GSK plc | Open Market Purchase | 3,300,000 | $5 | 2024-01-30 |
The information provided in this report about GSK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
GlaxoSmithKline plc(NYSE:GSK) 
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It op...
Website: http://www.gsk.com
Founded: 2000
Full Time Employees: 99,437
Sector: Healthcare
Industry: Drug Manufacturers-General